Bowel Dysfunction 3 Years After Anterior Resection a in a Swedish National Cohort

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-15

Study Completion Date

2020-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objectives are to evaluate the prevalence of LARS and Quality of Life in rectal cancer patients 3 years after anterior resection, to investigate if anastomotic technique is a risk factor for major LARS and to study the prevalence of colostomy 3 years after anterior resection and evaluate stoma function according to the stoma scale in EORTC QLQ-CR29.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bowel Dysfunction After Rectal Cancer Treatment

NCT05020132

Low Anterior Resection Syndrome

COMPLETED

Long - Term Low Anterior Resection Syndrome

NCT03920202

Bowel; Functional Syndrome

COMPLETED

Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery

NCT03215017

Low Anterior Resection Syndrome

COMPLETED NA

Defunctioning Stoma and Postoperative Morbidity

NCT01789515

Loopileostomy Fast Track Program,(Enhanced Recovery After Surgery (ERAS))

COMPLETED

Impact of a Patient-Centered Program for Low Anterior Resection Syndrome a Multicenter Randomized Controlled Trial

NCT03828318

Rectal Cancer Surgery Patient Activation +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients who have undergone anterior resection for rectal cancer between Q1 2015 and Q4 2017 have been identified in the Swedish Colorectal Cancer Registry (SCRCR). Three years after surgery the patients were sent a questionnaire including the LARS (Low Anterior Resection Syndrome)-score, the quality of life questionnaire EORTC QLQ 30 and CR29 in addition to a questionnaire regarding prevalence of remaining stoma.The patient cohort will be divided into two groups operated with total (TME) or partial (PME) mesorectal excision for further analyses. Patients with a stoma will be analysed separately.

Prevalence of major LARS and Quality of Life, QoL, 3 years after anterior resection will be assessed by the EORTC QLQ-C30 and by calculation of LARS Score with categories "no" (0-20 points), "minor" (21-29) and "major" (30-42). The LARS score will be dichotomized into the categories no/minor and major LARS.

Stoma function will be evaluated by the stoma scale in EORTC QLQ-CR29.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Anterior Resection Syndrome Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of rectal cancer in Sweden
* Operated on with anterior resection between Q1 2015 and Q4 2017 in Sweden, with or without defunctioning stoma